Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Autophagy

Items 11-20 of 32

Page
per page
  1. SAR405
    A8883 SAR405
     22 Citation
    Summary: Selective ATP-competitive inhibitor of Vps34
      ≥22.19 mg/mL
  2. SBI-0206965
    A8715 SBI-0206965
     2 Citation
    Target: ULK1
    Summary: ULK1 inhibitor
      ≥24.47 mg/mL
  3. Concanamycin A
    A8633 Concanamycin A
     1 Citation
    Target: Vacuolar-type ATPase
    Summary: V-type (vacuolar) H+-ATPase inhibitor
      soluble in DMSO
  4. (±)-Bay K 8644
    A8632 (±)-Bay K 8644
    Summary: L-type Ca2+-channel activator
      ≥36.2 mg/mL
  5. FK 866 hydrochloride
    A8631 FK 866 hydrochloride
    Target: NMPRTase
    Summary: NMPRTase inhibitor
      ≥18.95 mg/mL
  6. Xanthohumol
    A8630 Xanthohumol
    Summary: VCP inhibitor
      ≥121.6 mg/mL
  7. DBeQ
    A8629 DBeQ
    Target: P97 ATPase
    Summary: P97 ATPase inhibitor
      ≥16 mg/mL
  8. Chloroquine diphosphate
    A8628 Chloroquine diphosphate
     1 Citation
    Target: Autophagy
    Summary: Antimalarial drug, TLR7 and TLR9 inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥106.06 mg/mL
  9. Bafilomycin A1
    A8627 Bafilomycin A1
     5 Citation
    Summary: V-ATPases inhibitor
      Soluble in DMSO
  10. Wortmannin
    A8544 Wortmannin
     5 Citation
    Summary: PI3K inhibitor,selective and irreversible
      ≥21.42 mg/mL

Items 11-20 of 32

Page
per page